COVID-19 and pregnancy: A European study on pre- and post-infection medication use
ConclusionOur findings highlight the substantial impact of COVID-19 on primary care medication use among pregnant women, with a marked increase in the use of antithrombotic medications post-COVID-19. These results underscore the need for further research to understand the broader implications of these patterns on maternal and neonatal/fetal health outcomes.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Corticosteroid Therapy | COVID-19 | Databases & Libraries | Drugs & Pharmacology | France Health | Italy Health | Norway Health | Pandemics | Perinatology & Neonatology | Pregnancy | Primary Care | Spain Health | Study | Wales Health | Women